We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bbi Hldgs | LSE:BBI | London | Ordinary Share | GB00B00M4S16 | ORD 2.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 185.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:4899V Theratase PLC 25 April 2007 Proposed acquisition of Theratase plc ("the Company" or "Theratase") by BBI Holdings plc ("BBI") (to be effected by means of a Scheme of Arrangement) Result of the Theratase Court Meeting and the Theratase Extraordinary General Meeting On 27 March 2007, the Company announced a recommended proposal by BBI to acquire the entire issued and to be issued share capital of Theratase to be implemented by way of a Court approved Scheme of Arrangement. The Scheme Document, containing the terms and conditions of the Proposal and further information on the Proposal, was posted to qualifying holders of Theratase Shares (and to Theratase Optionholders, who received separate offers from BBI in respect of their Theratase Options, for information only) on 2 April 2007. Terms defined in this announcement have the same meanings as in the Scheme Document unless the context requires otherwise. The Company is pleased to announce that at the Theratase Court Meeting held earlier today, a resolution by holders of Theratase Shares to approve the Scheme was passed by a majority of those holders of Theratase Shares present in person or by proxy at the Theratase Court Meeting representing not less than 75 per cent. in value of the Theratase Shares held by such shareholders. The votes cast, either in person or by proxy, at the Theratase Court Meeting were as follows: For 11,803,606 Against 46,367 Result 99.61 per cent. of holders of Theratase Shares in favour The total number of holders of Theratase Shares voting in person or by proxy was 11,849,973. Of these, 11,803,606 voted for the Scheme representing approximately 99.61 per cent. of the total number of Theratase Shares represented at the Theratase Court Meeting and 46,367 voted against the Scheme representing approximately 0.39 per cent. of the total number of Theratase Shares represented at the Theratase Court Meeting. Following the Theratase Court Meeting, the Theratase Extraordinary General Meeting was held to consider a special resolution to approve the Scheme and certain other related matters. The Company is pleased to announce that the special resolution was passed at the Theratase Extraordinary General Meeting by the requisite majority. Completion of the Proposal remains subject to the satisfaction or, if permitted, waiver of the conditions to the Scheme as set out in the Scheme Document. It is expected that the Scheme will become effective on 15 May 2007. Enquiries: Theratase plc Tel: 020 7863 8819 Philip Percival, Chairman John Chesham, Chief Executive KBC Peel Hunt Ltd Tel: 020 7418 8900 Capel Irwin David Anderson KBC Peel Hunt Ltd, which is authorised and regulated in the UK by the Financial Services Authority, is acting as financial adviser and broker to Theratase in connection with the Proposal and no-one else and will not be responsible to anyone other than Theratase for providing the protections afforded to clients of KBC Peel Hunt Ltd nor for providing advice in relation to the Proposal nor any other matter referred to in this announcement. The Theratase Directors, whose names are set out in the Scheme Document, accept responsibility for the information contained in this announcement. To the best of the knowledge and belief of the Theratase Directors (who have taken all reasonable care to ensure that such is the case), the information contained in this announcement is in accordance with the facts and does not omit anything likely to affect the import of such information. This information is provided by RNS The company news service from the London Stock Exchange END REGBBGDSCBDGGRU
1 Year Bbi Holdings Chart |
1 Month Bbi Holdings Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions